Policy Briefs on THE

ECONOMIC IMPACT OF HIV

Impact of HIV

Brief 6: Productivity and Employment of People Living with HIV

By Markus Haacker, Kate Harris, Gesine Meyer-Rath

21 January 2021

Key Points

  • Early on, there were concerns that AIDS-related mortality would erode state governance and institutions and thus compromise economic development, but there is little evidence to suggest that such effects have been significant.
  • HIV – especially at late stages of disease progression – results in reduced productivity and lower employment of people living with HIV, though the economy-wide effects are unclear.
  • Treatment has been effective in restoring the productivity and – with some delay – employment of people living with HIV.

  • Early access to treatment plausibly prevents spells of unemployment, which are an important cause of the adverse economic consequences of HIV.

Technical Briefs

The technical briefs provide more detail on the evidence available on each of the topics.

1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality

2. Increased Health and Life Prospects and Their Economic Valuation

3. HIV, Population Dynamics and the Labour Force

4. Human Capital

5. Capital and Investment

6. Productivity and Employment of People Living with HIV

7. Economic Growth – Overview

8. Interactions Between HIV and Poverty

9. Disease Burden Across Population Sub-Groups

10. Trade-offs between Allocation to Health and Other Sectors

11. Domestic Public Funding for HIV

12. Trade-offs and Synergies between HIV and Other Health Objectives

13. Assessing Cost Effectiveness Across HIV and Health Interventions

14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding

15. Public and Private Provision of Health and HIV Services

16. Trade-offs within the HIV Budget

17. The Economics of HIV and of HIV Programmes in the Era of Covid-19

Brief 6: Productivity and Employment of People Living with HIV

By Markus Haacker, Kate Harris, Gesine Meyer-Rath

21 January 2021

Key Points

  • Early on, there were concerns that AIDS-related mortality would erode state governance and institutions and thus compromise economic development, but there is little evidence to suggest that such effects have been significant.
  • HIV – especially at late stages of disease progression – results in reduced productivity and lower employment of people living with HIV, though the economy-wide effects are unclear.
  • Treatment has been effective in restoring the productivity and – with some delay – employment of people living with HIV.

  • Early access to treatment plausibly prevents spells of unemployment, which are an important cause of the adverse economic consequences of HIV.

Technical Briefs

The technical briefs provide more detail on the evidence available on each of the topics.

1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality

2. Increased Health and Life Prospects and Their Economic Valuation

3. HIV, Population Dynamics and the Labour Force

4. Human Capital

5. Capital and Investment

6. Productivity and Employment of People Living with HIV

7. Economic Growth – Overview

8. Interactions Between HIV and Poverty

9. Disease Burden Across Population Sub-Groups

10. Trade-offs between Allocation to Health and Other Sectors

11. Domestic Public Funding for HIV

12. Trade-offs and Synergies between HIV and Other Health Objectives

13. Assessing Cost Effectiveness Across HIV and Health Interventions

14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding

15. Public and Private Provision of Health and HIV Services

16. Trade-offs within the HIV Budget

17. The Economics of HIV and of HIV Programmes in the Era of Covid-19

Wits Health Consortium, University of the Witwatersrand